ORBIS AG (ETR:OBS)
Germany · Delayed Price · Currency is EUR 4.680
-0.080 (-1.68%)
Oct 2, 2026, 5:35 PM CET
ORBIS AG Revenue
ORBIS AG had revenue of 68.11M EUR in the half year ending June 30, 2026, with 1.17% growth. This brings the company's revenue in the last twelve months to 135.64M, up 1.03% year-over-year. In the year 2025, ORBIS AG had annual revenue of 135.34M with 1.93% growth.
Revenue (ttm)
135.64M
Revenue Growth
+1.03%
P/S Ratio
0.33
Revenue / Employee
150.49K
Employees
898
Market Cap
44.32M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 135.34M | 2.56M | 1.93% |
| Dec 31, 2024 | 132.78M | -3.02M | -2.23% |
| Dec 31, 2023 | 135.80M | 11.74M | 9.46% |
| Dec 31, 2022 | 124.06M | 23.59M | 23.48% |
| Dec 31, 2021 | 100.47M | 12.45M | 14.15% |
| Dec 31, 2020 | 88.02M | 32.21M | 57.71% |
| Dec 31, 2019 | 55.81M | -8.53M | -13.26% |
| Dec 31, 2018 | 64.34M | 13.29M | 26.04% |
| Dec 31, 2017 | 51.05M | 4.25M | 9.08% |
| Dec 31, 2016 | 46.80M | 3.54M | 8.19% |
| Dec 31, 2015 | 43.26M | 3.04M | 7.57% |
| Dec 31, 2014 | 40.21M | 3.14M | 8.48% |
| Dec 31, 2013 | 37.07M | 1.01M | 2.79% |
| Dec 31, 2012 | 36.06M | 8.40M | 30.37% |
| Dec 31, 2011 | 27.66M | 1.85M | 7.17% |
| Dec 31, 2010 | 25.81M | 2.69M | 11.65% |
| Dec 31, 2009 | 23.12M | -1.49M | -6.05% |
| Dec 31, 2008 | 24.61M | 1.79M | 7.82% |
| Dec 31, 2007 | 22.82M | 2.28M | 11.09% |
| Dec 31, 2006 | 20.54M | -374.90K | -1.79% |
| Dec 31, 2005 | 20.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cancom SE | 1.69B |
| adesso SE | 1.56B |
| All for One Group SE | 502.97M |
| init innovation in traffic systems SE | 388.83M |
| Allgeier SE | 342.33M |
| q.beyond AG | 177.64M |
| KPS AG | 111.70M |
| Softing AG | 79.60M |
ORBIS AG News
- 16 days ago - Novo, Orbis sign up to $1.4 billion deal to develop oral drugs - Reuters
- 2 months ago - ICON, Anthropic Sign Multi-Year Partnership Deal To Advance AI Capabilities, Stock Up In Pre-Market - Nasdaq
- 5 months ago - FedEx and Orbis Earn "Best of the Best" Halo Award: Delivering Sight Worldwide - Wallstreet:Online
- 5 months ago - Agitated Solutions, Incorporated: Agitated Solutions Receives CE Mark Approval for Orbis Microbubble Generator - Finanz Nachrichten
- 1 year ago - NBA Legend's Eco-Friendly Hemp Packaging Shakes Up Auto Industry: Unveiled At Detroit Showcase - Benzinga